The Center for Fetal Diagnosis and Treatment currently is participating in the following clinical studies:
MOMS is a national clinical trial comparing two treatment approaches to spina bifida -- prenatal surgical repair versus postnatal surgical repair, the current standard of care. The study plans to enroll 200 pregnant women carrying fetuses diagnosed with myelomeningocele. Get more information about this study.
Principal Investigator: Mark P. Johnson, MD
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development
This multi-site study will compare two tests for prenatal diagnosis of chromosome problems. The new method, called microarray testing, will be compared to the standard testing in current use. The study population will include patients presenting for amniocentesis or chorionic villus sampling (CVS). For more information, please visit: www.microarraystudy.org